Cancer Research UK says the new approach should mean fewer people with inflammatory bowel disease will need to undergo surgery or regular colonoscopies.
Me is considering a sale of the company as it weighs up strategic options, capping a torrid year for the genetic testing business. A special committee of its directors’ board is considering various ...